Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Tea and coffee consumption and risk of acute stroke: The INTERSTROKE Study
Indexado
WoS WOS:001283023000001
Scopus SCOPUS_ID:85200115743
DOI 10.1177/17474930241264685
Año 2024
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Background: Stroke is a leading global cause of death and disability. Daily tea/coffee intake is consumed by > 50% of populations and may represent an important population-level exposure. Therefore, it is first essential that we better understand the associations between the tea/coffee intake and stroke. Aims: This research aims to generate hypotheses about the global associations between tea and coffee intake and stroke. These insights will identify interventions for stroke prevention that can be further explored using alternative study designs. Methods: INTERSTROKE is a large international matched case-control study of first stroke from 32 countries. Participants were asked "how many cups do you drink each day?" of coffee, green tea, black tea, and other tea. Multivariable conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between intake and stroke. Results: We included 13,462 cases and 13,488 controls from INTERSTROKE; mean age was 61.7 (13.4) years and 59.6% (n = 16,010) were male. Overall, 19.4% (n = 5239) did not consume tea/coffee, 47.0% (n = 12,666) consumed tea only, 14.9% (n = 4024) consumed coffee alone, and 18.6% (n = 5021) consumed both, with significant regional variations. After multivariable adjustment, there was no association between low/moderate coffee intake and stroke, but high consumption (> 4/day) was associated with higher odds of all stroke (OR = 1.37 (95% CI = 1.06-1.77)) or ischemic stroke (OR = 1.32 (95% CI = 1.00-1.74)). Tea consumption was associated with lower odds of all (OR = 0.81 (95% CI = 0.69-0.94) for highest intake) or ischemic stroke (OR = 0.81 (95% CI = 0.68-0.98) for highest intake). Conclusions: High coffee consumption was associated with higher odds of all or ischemic stroke; low-moderate coffee had no association with stroke. In contrast, tea consumption was associated with lower odds of stroke. These associations suggest that individuals consider avoiding high coffee consumption (>= five cups/day) to impact future stroke risk. Data Access Statement: The design and rationale of INTERSTROKE was published previously. Individual participant data, or other documents are not available.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Clinical Neurology
Peripheral Vascular Disease
Peripheral Vascular Diseases
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Smyth, Andrew Hombre MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá
Univ Galway - Irlanda
Hamilton Health Sciences - Canadá
University of Galway - Irlanda
2 Hankey, Graeme J. Hombre Univ Western Australia - Australia
UWA Medical School - Australia
3 Langhorne, Peter Hombre Univ Glasgow - Reino Unido
University of Glasgow - Reino Unido
4 Reddin, Catriona - Univ Galway - Irlanda
University of Galway - Irlanda
5 Ryglewicz, Danuta Mujer Mil Inst Aviat Med - Polonia
Military Institute of Aviation Medicine - Polonia
6 Rosengren, Annika Mujer Univ Gothenburg - Suecia
Sahlgrenska Universitetssjukhuset - Suecia
7 Xavier, Denis Hombre St Johns Med Coll & Res Inst - India
St. John's National Academy Of Health Sciences India - India
8 Canavan, M. Mujer Univ Galway - Irlanda
University of Galway - Irlanda
9 Oveisgharan, Shahram Hombre Rush Univ - Estados Unidos
Rush University Medical Center - Estados Unidos
10 Wang, Xingyu - Beijing Hypertens League Inst - China
Beijing Hypertension League Institute - China
11 Jaramillo, Patricio Lopez - Univ Santander - Colombia
Univ UTI - Ecuador
Universidad de Santander - Colombia
Universidad UTI - Ecuador
12 Damasceno, Albertino Hombre Eduardo Mondlane Univ - Mozambique
Universidade Eduardo Mondlane - Mozambique
13 Czlonkowska, Anna Mujer Inst Psychiat & Neurol - Polonia
Institute of Psychiatry and Neurology, Warszawa - Polonia
14 Iversen, Helle K. Mujer Univ Copenhagen - Dinamarca
Rigshospitalet - Dinamarca
15 LANAS-ZANETTI, FERNANDO TOMAS Hombre Universidad de La Frontera - Chile
16 Yusuf, Salim Hombre MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá
Hamilton Health Sciences - Canadá
17 O’Donnell, Martin J. Hombre MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá
Univ Galway - Irlanda
Hamilton Health Sciences - Canadá
University of Galway - Irlanda

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
National Institutes of Health
European Commission
European Union
DFG
BMBF
Swedish Research Council
Stroke Association
Bundesministerium für Bildung und Forschung
Boehringer Ingelheim (Canada)
Swedish Heart and Lung Foundation
AstraZeneca
Boehringer Ingelheim
German Ministry of Education and Research (BMBF)
MSD
German Research Council
German Research Council (DFG)
Chest, Heart and Stroke Scotland
Pfizer (Canada)
UK Stroke Research Network
Canadian Stroke Network
Bertelsmann Foundation
Heinz-Nixdorf Foundation
Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland
Chest Heart and Stroke Scotland
Hjärt-Lungfonden
Canadian Institutes of Health Research, Heart and Stroke Foundation (Canada)
Health & Medical Care Committee of the Vaestra Goetaland Regional Executive Board (Sweden)
Stroke Association, UK Stroke Research Network
Canadian Institutes of Health Research, Heart and Stroke Foundation

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The INTERSTROKE study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation (Canada), Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, Health & Medical Care Committee of the Vaestra Goetaland Regional Executive Board (Sweden), unrestricted grants (AstraZeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MSD), Chest, Heart and Stroke Scotland, and the Stroke Association, UK Stroke Research Network, German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, National Institutes of Health, Bertelsmann Foundation, and Heinz-Nixdorf Foundation.
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The INTERSTROKE study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation (Canada), Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, Health & Medical Care Committee of the V\u00E4stra G\u00F6taland Regional Executive Board (Sweden), unrestricted grants (AstraZeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MSD), Chest, Heart and Stroke Scotland, and the Stroke Association, UK Stroke Research Network, German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, National Institutes of Health, Bertelsmann Foundation, and Heinz-Nixdorf Foundation.

Muestra la fuente de financiamiento declarada en la publicación.